Ara
Toplam kayıt 8, listelenen: 1-8
New Oral Treatments Expected to be Available for Multiple Sclerosis
(AVES, 2011)
Several disease-modifying drugs are actually approved for the treatment of relapsing-remitting and secondary progressive multiple sclerosis. These common therapies have three major disadvantages: (1) they only have a limited ...
Impact of Earthquake on Multiple Sclerosis Attacks
(GALENOS YAYINCILIK, 2010)
Objective: The association between stressful life events and subsequent multiple sclerosis (MS) attacks has been frequently reported with conflicting results. In this study, we investigated the impact of a common stressor ...
Uveitis as a prognostic factor in multiple sclerosis
(SAGE PUBLICATIONS LTD, 2015)
Uveitis is occasionally encountered in multiple sclerosis (MS) patients. The objective of this report is to investigate whether uveitis has a prognostic impact on the clinical course of MS. Several clinical and demographic ...
The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature
(SPRINGER HEIDELBERG, 2017)
It has long been known that the majority of patients with multiple sclerosis (MS) display an intrathecal, polyspecific humoral immune response to a broad panel of neurotropic viruses. This response has measles virus, rubella ...
Effect of short-term interferon-beta treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23
(ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 2012)
Therapeutic effect of interferon-beta (IFN-beta) treatment has been associated with modulation of the balance between Th1, Th17, Th2 and regulatory T (Treg) cells, whereas the impact of disease modifying drugs on Th9-immunity ...
Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse
(SPRINGER BASEL AG, 2012)
To identify an antibody biomarker for multiple sclerosis (MS) that can be used as a predictor of MS relapses. MS patients' sera were screened by a protein macroarray derived from human fetal brain cDNA library (hEX1). Sera ...
Evaluation of Normal Appearing White Matter in Multiple Sclerosis Comparison of Diffusion Magnetic Resonance, Magnetization Transfer Imaging and Multivoxel Magnetic Resonance Spectroscopy Findings with Expanded Disability Status Scale
(SPRINGER HEIDELBERG, 2011)
Purpose The aim of this study was to determine diffusion magnetic resonance imaging (MRI), magnetization transfer (MT) imaging and multivoxel MR spectroscopy findings in plaques, periplaque white matter and normal appearing ...
The relationship of cognitive impairment with neurological and psychiatric variables in multiple sclerosis patients
(TAYLOR & FRANCIS LTD, 2014)
Objective. Cognitive impairment (CI) in multiple sclerosis (MS) can develop any time. CI is associated with the degree of neuronal loss, but disease duration, fatigue, comorbid affective disorder, and drug dose may also ...